A novel approach to studying the progression of tuberculosis (TB) from infection to disease has identified and treated people at increased risk of developing the disease that current methods of testing would not.
Exclusive: After CureVac, Igor Splawski moves to RTW stealth startup; Lyndra’s Jessica Ballinger adds CEO title amid commercial prep
A chunky chain necklace, matching earrings, and a floral shirt with a dozen colors — that’s Igor Splawski. The former chief scientist at CureVac has